Hilarious and painfully true!

If you are between the ages of 18-39 & have cancer (any stage you may be eligible for a research study that aims to address individuals’ needs related to post-treatment problems. More: bit.ly/EAQ202 cc: John M. Salsman, Lynne I Wagner PhD, Ruth Carlos, Stupid Cancer

So excited to see all that you'll accomplish! Your fans across #NCTN , #NCORP and ECOG-ACRIN Cancer Research Group are cheering for you!

Lynne I. Wagner – Childhood Cancer Researcher cancer.gov/research/areas…
Grateful for opportunity to share my story and why I'm passionate about #patientreportedoutcomesresearch ! And for wonderful #AYA collaborators John M. Salsman Brad Zebrack Michael Roth Wake Forest Baptist - Comprehensive Cancer Center ECOG-ACRIN Cancer Research Group National Cancer Institute

Exciting research led by colleague Stephanie Sohl! Stephanie J. Sohl

#Clinicaltrial EA8184, led by Dr. Nagi Kumar of Moffitt Cancer Center will evaluate if #greentea catechins can help prevent the progression of #prostatecancer in men on active surveillance. Learn more here: bit.ly/ea8184trial #pcsm cc: juan luis pow sang campos

I was honored to join Dr. Kimryn Rathmell during ECOG-ACRIN Cancer Research Group Group meeting to celebrate Dr. Worta McCaskill-Stevens' leadership and accomplishments in #NCORP to reduce #cancerdisparities and improve #clinicaltrial access National Cancer Institute NCI Prevention & Early Detection Wake Forest University School of Medicine Atrium Health Wake Forest Baptist NCI Supportive Care

“We will work together to reinvent how we approach, design, and conduct #clinicaltrials , and report results.” - Dr. Kimryn Rathmell

Thank you for joining us last night & sharing your vision for the future of #CancerResearch ! More: bit.ly/3FsgGvB

Happy fall Chicagoans! I miss this view

If you are between the ages of 18-39 & have cancer (any stage you may be eligible for a research study that aims to address individuals’ needs related to post-treatment problems. More: bit.ly/EAQ202 cc: John M. Salsman, Lynne I Wagner PhD, Ruth Carlos, Stupid Cancer

.Lynne I Wagner PhD Samilia Obeng-Gyasi, MD, MPH

Great work Rebecca Erwin Wells, MD, MPH, FAHS, FAAN! Wake Forest University School of Medicine

You're on, Michael Roth!

PRO researchers everywhere are cheering! Fantastic support for the critical role of patient-rated symptoms to ensure high quality cancer care

For those who want to read it! ⁦ECOG-ACRIN Cancer Research Group⁩ ⁦ASCO⁩ ⁦American College of Radiology⁩ #TMIST

Excited to share FoRtitude results! Grateful for collaboration with 3 NCI Community Oncology Research Program sites to enroll geographically diverse sample of women from community oncology practices. FoRtitude 2.0 in development through ECOG-ACRIN Cancer Research Group

For those of us attending ASCO virtually, thanks for painting a vivid picture George W Sledge MD! So lucky to be on this journey together to reduce the burden of cancer #ASCO2022

This is a big deal for future clinical trial development. How to engage investigators to enroll their patients in prospective #OptimizationTrials testing if #LessIsMore , and successfully avoid chemo for patients who don't need it. ECOG-ACRIN Cancer Research Group

Great session on Strategies to Advance Equity in CA Clinical trials with powerful reminder from Lori Pierce that providers are one important piece to enrolling diverse pts. Gabrielle results on physician perspectives is an important step forward in efforts to improve equity!

Way to go Pamela Kunz, MD, FASCO outlining the disparities in leadership of oncology clinical trials on the center stage! 👏🏼👏🏼👏🏼